Amphotericin shortage status
2 active shortage notices across 1 country.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Amphotericin
- Class
- Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Where Amphotericin is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| New Zealand | high | 2 | 14 Oct 2026 | — | Pharmac |
Why Amphotericin is in shortage
- supply-chain disruption — e.g. “Boucher & Muir (BNM), the supplier, has placed a quality hold on their stock (and wholesalers' stock) of Amphotericin Liposomal SUN 50 mg vial (Pharmacode 2714264).” (New Zealand)
Frequently asked questions
Is Amphotericin currently in shortage?
Yes. As of the latest regulator updates, Amphotericin has 2 active shortage notices across 1 country (New Zealand). Status is refreshed daily from official regulatory sources.
Why is Amphotericin in shortage?
Regulators attribute the current Amphotericin shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Amphotericin shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Amphotericin status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.